Owner ViroChem Pharma Inc.

Inventors Moinet, Christophe; Chan Chun Kong, Laval; Halab, Liliane; Turcotte, Nathalie; Bubenik, Monica; Courchesne, Marc; Poisson, Carl; Pereira, Oswy Z.; Nguyen-Ba, Paul; Liu, Bingcan; Chauret, Nathalie; Cadilhac, Caroline

Agent Baldwins

Pub. Number AU-A-2008342537

PCT Pub. Number WO2009/082819

Priority 61/039,660 26.03.08 US; 61/018,759 03.01.08 US

Filing date 23 December 2008

Wipo publication date 9 July 2009

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

C07J 63/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms